← Leaderboards
Aliasger K Salem
University Of Iowa
$2,971,479
Attributed
$5,344,929
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $690.5K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,344,929 · 9
By mechanism
U01$2,652,788 · 1
R21$1,876,125 · 5
R01$588,731 · 1
P30$227,285 · 2
Top collaborators
- Maneesh Jain5 shared
- Balaji Narasimhan5 shared
- Mark Aaron Greiner3 shared
- Sara Michelle Thomasy1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Joseph J Cullen$5,964,157
- Garry R Buettner$6,434,018
- Bryan Allen$2,697,856
- Melissa Ann Fath$775,635
- Kyungsup Shin$1,616,859
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleBaseResponseModalityInnovationSolid NeoplasmCancer ImmunotherapyPeer ReviewMalignant NeoplasmsLeadCellsDesignImmunizationEvaluationClinical TrialsIn SituNanoMultidisciplinaryNovel TherapeuticsMultiple MyelomaProgramsNovel StrategiesCollegeInvestigational Therapies
Grant awards (28)
Modulating Ferroptosis in Fuchs Endothelial Corneal Dystrophy$588,731
R01 · FY2025 · EY
Cationic CAMKIIN nanoparticles that reduce chlorine-induced airway oxidative stress$231,750
R21 · FY2023 · ES · contact PI
CST6-mRNA activated matrices for efficient bone regeneration$231,750
R21 · FY2023 · DE · contact PI
Optimizing Rho-associated kinase inhibitors for use in treating Fuchs endothelial corneal dystrophy$193,125
R21 · FY2023 · EY
Experimental Therapeutics$33,883
P30 · FY2023 · CA · contact PI
Optimizing Rho-associated kinase inhibitors for use in treating Fuchs endothelial corneal dystrophy$231,750
R21 · FY2022 · EY
Cationic CAMKIIN nanoparticles that reduce chlorine-induced airway oxidative stress$193,125
R21 · FY2022 · ES · contact PI
CST6-mRNA activated matrices for efficient bone regeneration$193,125
R21 · FY2022 · DE · contact PI
Experimental Therapeutics$33,883
P30 · FY2022 · CA · contact PI
Nanovaccine platforms to combat pancreatic cancer$507,337
U01 · FY2021 · CA
Nanovaccine platforms to combat pancreatic cancer$506,063
U01 · FY2020 · CA
Program 2: Experimental Therapeutics$27,356
P30 · FY2020 · CA · contact PI
Nanovaccine platforms to combat pancreatic cancer$529,150
U01 · FY2019 · CA
Program 2: Experimental Therapeutics$27,356
P30 · FY2019 · CA · contact PI
Nanovaccine platforms to combat pancreatic cancer$543,977
U01 · FY2018 · CA
Program 2: Experimental Therapeutics$27,356
P30 · FY2018 · CA · contact PI
Program 2: Experimental Therapeutics$7,201
P30 · FY2018 · CA · contact PI
Program 2: Experimental Therapeutics$6,879
P30 · FY2018 · CA · contact PI
Program 2: Experimental Therapeutics$4,902
P30 · FY2018 · CA · contact PI
Program 2: Experimental Therapeutics$3,645
P30 · FY2018 · CA · contact PI
Program 2: Experimental Therapeutics$1,699
P30 · FY2018 · CA · contact PI
Nanovaccine platforms to combat pancreatic cancer$566,261
U01 · FY2017 · CA
Program 2: Experimental Therapeutics$23,461
P30 · FY2017 · CA · contact PI
Program 2: Experimental Therapeutics$29,664
P30 · FY2016 · CA · contact PI
Engineered Optimal Adjuvant and Antigen Release from Biodegradable Nanoparticles$132,000
R21 · FY2010 · CA · contact PI
Chitosan-plasmid DNA nanoplexes and adenoviruses as prostate cancer vaccines$168,750
R21 · FY2009 · CA · contact PI
Engineered Optimal Adjuvant and Antigen Release from Biodegradable Nanoparticles$132,000
R21 · FY2009 · CA · contact PI
Chitosan-plasmid DNA nanoplexes and adenoviruses as prostate cancer vaccines$168,750
R21 · FY2008 · CA · contact PI